Citadel Advisors »

Better Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Better Therapeutics (BTTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Better Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Better Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Better Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $43k 219k 0.20
2023-09-30 $12k 31k 0.39
2023-03-31 $35k 48k 0.73
2022-12-31 $279k 249k 1.12
2022-06-30 $170k 109k 1.56
2022-03-31 $214k 107k 1.99
2021-12-31 $633k 136k 4.64

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Better Therapeutics

Capital Investment Advisory Services
XTX Topco
Aspire Private Capital

View all funds holding Better Therapeutics